Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD). [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics, pharmacodynamics, and efficacy of Crovalimab for the management of acute uncomplicated vaso-occlusive episode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Crovalimab (crovalimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED